Icon

EXBLIFEP (NDA216165)- (EQ 2GM BASE/VIAL;0.5GM/VIAL)

CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM ALLECRA THERAPS
EQ 2GM BASE/VIAL;0.5GM/VIAL
No Yes
2034-Nov-07 2029-Feb-22
None None
None No
EXBLIFEP is a combination of cefepime, a cephalosporin antibacterial, and enmetazobactam, a beta-lactamase inhibitor, indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 2GM BASE/VIAL;0.5GM/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.